MBX Biosciences, Inc. Common Stock (MBX) News
Latest headlines that mention MBX, newest first · each headline opens the original publisher
- Last price
- $54.20
- Day change
- +5.56%
- Next earnings
- —
MBX headlines
latest coverageMBX Biosciences, a clinical-stage biotech developing peptide therapies, reported a notable insider sale after a year of rapid stock gains.
MBX news alerts
Get an alert by email or push when a new headline mentions MBX.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.